Active Ingredients

cyclobenzaprine hydrochloride

Extended-release Capsules (CER) employs Diffucaps drug delivery technology allowing for once-daily dosing.

Indications

• Prinorelax® (cyclobenzaprine hydrochloride)  is indicated by FDA as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion.

Mode of Action

• Prinorelax ® relieves skeletal muscle spasm of local origin without interfering with muscle function

• Cyclobenzaprine has not been shown to be effective in muscle spasm due to central nervous system disease. Evidence suggests that the net effect of cyclobenzaprine is a reduction of tonic somatic motor activity, influencing both gamma (g) and alpha (a) motor systems. Pharmacological studies in animals demonstrated a similarity between the effects of cyclobenzaprine and the structurally related tricyclic antidepressants.

The recommended adult dose for most patients is one (1) PRINORELAX 15mg capsule taken once daily.

Some patients may require up to 30mg/day, given as one (1) PRINORELAX  30mg capsule taken once daily or as two (2) PRINORELAX  15mg capsules taken once daily.

Dose

• Package

Prinorelax ® 10 Caps (1 strips)

 

• Storage

Store below 30°C in a dry place

All Rights Reserved Liptis Pharmaceuticals 2021